¼¼°èÀÇ Ç÷±¸ ºÐ¼®±â ½ÃÀå
Blood Cell Analyzer
»óǰÄÚµå : 1763161
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 193 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,106,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,320,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ Ç÷±¸ ºÐ¼®±â ½ÃÀåÀº 2030³â±îÁö 27¾ï ´Þ·¯¿¡ µµ´Þ

2024³â¿¡ 21¾ï ´Þ·¯·Î ÃßÁ¤µÈ ¼¼°èÀÇ Ç÷±¸ ºÐ¼®±â ½ÃÀåÀº ºÐ¼® ±â°£ÀÎ 2024-2030³â¿¡ CAGR 4.8%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 27¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ¸®Æ÷Æ®¿¡¼­ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀÎ ¹ÝÀÚµ¿ »ýÈ­ÇÐ ºÐ¼®±â´Â CAGR 4.5%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 6¾ï 8,760¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀüÀÚµ¿ »ýÈ­ÇÐ ºÐ¼®±â ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ Áß CAGR 5.0%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 5¾ï 6,130¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 4.4%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ Ç÷±¸ ºÐ¼®±â ½ÃÀåÀº 2024³â¿¡ 5¾ï 6,130¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº ºÐ¼® ±â°£ÀÎ 2024-2030³âÀÇ CAGR 4.4%·Î ÃßÀÌÇϸç, 2030³â¿¡´Â 4¾ï 2,560¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 4.7%¿Í 3.9%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 3.9%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ Ç÷±¸ ºÐ¼®±â ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

Àü ¼¼°è¿¡¼­ Ç÷±¸ °è¼ö±â ¼ö¿ä°¡ ±ÞÁõÇÏ´Â ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

Ç÷±¸ ºÐ¼®±â ¼ö¿ä°¡ ±ÞÁõÇϰí ÀÖ´Â °ÍÀº ÇコÄÉ¾î ºÐ¾ß¿¡¼­ Á¤¹ÐÇÏ°í ½Å¼ÓÇÑ Áø´Ü Åø¿¡ ´ëÇÑ ¿ä±¸°¡ Áõ°¡Çϰí Àֱ⠶§¹®ÀÔ´Ï´Ù. Ç÷±¸ ºÐ¼®±â´Â °¨¿°, ºóÇ÷, ¾Ï, ½ÉÇ÷°ü Áúȯ µî ´Ù¾çÇÑ ÁúȯÀÇ Áø´Ü¿¡ ÇʼöÀûÀÔ´Ï´Ù. ƯÈ÷ °í·ÉÈ­ »çȸ¿¡¼­ ÀÌ·¯ÇÑ ÁúȯÀÇ À¯º´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õµéÀº ȯÀÚÀÇ ¿¹Èĸ¦ °³¼±Çϱâ À§ÇØ Ã·´Ü Ç÷±¸ ºÐ¼® ±â¼ú¿¡ ÁÖ¸ñÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Àåºñ´Â ÀÇ·á Àü¹®°¡°¡ Ç÷¾× »ùÇÃÀ» ÀÚ¼¼È÷ Æò°¡ÇÏ°í ¼¼Æ÷ ¼ö, ÇüÅÂ, ÀÌ»óÀ» ÃøÁ¤ÇÏ¿© ½Å¼ÓÇϰí Á¤È®ÇÑ °á°ú¸¦ Á¦°øÇÒ ¼ö ÀÖ°Ô ÇØÁÝ´Ï´Ù. ÀÇ·á°¡ ¿¹¹æ ÀÇ·á¿Í Á¶±â Áø´ÜÀ¸·Î ÀüȯµÊ¿¡ µû¶ó Ç÷¾× ¼¼Æ÷ ºÐ¼®±âÀÇ ¿ªÇÒÀº ´õ¿í Áß¿äÇØÁú °ÍÀÔ´Ï´Ù.

±â¼ú Çõ½ÅÀº Ç÷±¸ °è¼ö±â¸¦ ¾î¶»°Ô º¯È­½Ãų °ÍÀΰ¡?

±â¼ú ¹ßÀüÀº Ç÷±¸ ºÐ¼®±â ½ÃÀå ¼ºÀåÀÇ ÃÖÀü¼±¿¡ ÀÖÀ¸¸ç, º¸´Ù È¿À²ÀûÀ̰í Á¤È®ÇÑ ´Ù±â´É ±â±â·Î À̾îÁö°í ÀÖ½À´Ï´Ù. ÀΰøÁö´É(AI)°ú ¸Ó½Å·¯´×ÀÌ ºÐ¼®±â¿¡ ÅëÇÕµÇ¾î »ç¶÷ÀÇ °³ÀÔÀ» ÃÖ¼ÒÈ­Çϸ鼭 ½Å¼ÓÇÑ ÀÚµ¿ Áø´ÜÀÌ °¡´ÉÇØÁ® ¿À·ù °¡´É¼ºÀ» ÁÙÀÌ°í °Ë»ç½ÇÀÇ È¿À²¼ºÀ» ³ôÀ̰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ À¯¼¼Æ÷ºÐ¼® ¹× Ç÷¾×ÇÐÀÇ ¹ßÀüÀ¸·Î Èñ±Í Ç÷¾× ÁúȯÀ» ½Äº°ÇÏ´Â µî Ç÷¾× »ùÇÃÀ» º¸´Ù »ó¼¼ÇÏ°Ô ºÐ¼®ÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ÈÞ´ë¿ë ÇöÀå Ç÷¾× ºÐ¼®±â ¶ÇÇÑ Àα⸦ ¾ò°í ÀÖÀ¸¸ç, Áø·á¼Ò, Áö¹æ º´¿ø, ÀçÅÃÄ¡·á ÇöÀå µî ºÐ»êµÈ ȯ°æ¿¡¼­ Áø´ÜÀ» °¡´ÉÇÏ°Ô Çϰí ÀÖ½À´Ï´Ù.

½ÅÈï ½ÃÀåÀº Ç÷¾× ¼¼Æ÷ ºÐ¼®±â »ê¾÷¿¡ ¾î¶² ¿µÇâÀ» ¹ÌÄ¡°í Àִ°¡?

½ÅÈï ½ÃÀåÀº Ç÷±¸ ºÐ¼®±â »ê¾÷¿¡¼­ Á¡Á¡ ´õ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖÀ¸¸ç, ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ƯÈ÷ ¾Æ½Ã¾ÆÅÂÆò¾ç°ú ¶óƾ¾Æ¸Þ¸®Ä«ÀÇ °³¹ßµµ»ó±¹¿¡¼­´Â ÀÇ·áºñ ÁöÃâÀÌ Áõ°¡Çϰí Áø´Ü ¼­ºñ½º¿¡ ´ëÇÑ Á¢±Ù¼ºÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù. À̵é Áö¿ªÀÇ ÀÇ·á ÀÎÇÁ¶ó°¡ °³¼±µÊ¿¡ µû¶ó Ç÷±¸ ºÐ¼®±â¸¦ Æ÷ÇÔÇÑ ÃֽŠÁø´Ü Åø¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÇ·á ¼­ºñ½º Á¢±Ù¼º È®´ë¿Í ¾Ï ¹× ´ç´¢º´°ú °°Àº Áúº´¿¡ ´ëÇÑ °ËÁø ÇÁ·Î±×·¥À» À§ÇÑ Á¤ºÎÀÇ ±¸»óÀº ÷´Ü Áø´Ü ÀåºñÀÇ Ã¤ÅÃÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¿¹¹æ ÀÇ·á¿Í Á¶±â Áø´Ü¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó À̵é Áö¿ª¿¡¼­ Ç÷¾× ºÐ¼®±â¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

Ç÷¾× ¼¼Æ÷ ºÐ¼®±â ½ÃÀåÀÇ ¼ºÀåÀº ¸î °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµË´Ï´Ù.

Ç÷±¸ ºÐ¼®±â ½ÃÀåÀÇ ¼ºÀåÀº ±â¼ú ¹ßÀü, ¸¸¼ºÁúȯ ¹× °¨¿°¼º ÁúȯÀÇ À¯Çà, ½ÅÈï ½ÃÀåÀÇ ÀÇ·áºñ Áõ°¡ µî ¿©·¯ ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ¼¼°è Àα¸ÀÇ °í·ÉÈ­¿Í ÀÌ¿¡ µû¸¥ ³ëÈ­ °ü·Ã Áúȯ Áõ°¡´Â ÀÌ·¯ÇÑ Áø´Ü Åø¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿¡ Å©°Ô ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ º¸´Ù ½Å¼ÓÇϰí Á¤È®ÇÑ °á°ú¿¡ ´ëÇÑ ¿ä±¸·Î ÀÎÇØ °Ë»ç½ÇÀÇ ÀÚµ¿È­ Ãß¼¼°¡ °­È­µÇ°í ÀÖ´Â Á¡µµ Ç÷¾× ¼¼Æ÷ ºÐ¼®±âÀÇ Ã¤ÅÃÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ÇöÀå °Ë»ç, ÀçÅà Áø´Ü, ¿¹¹æ ÀÇ·á·ÎÀÇ Àüȯµµ ½ÃÀå È®´ë¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖÀ¸¸ç, ¼ÒºñÀÚ¿Í ÀÇ·áÁø ¸ðµÎ º¸´Ù Á¢±ÙÇϱ⠽±°í È¿À²ÀûÀÎ Áø´Ü ¼Ö·ç¼ÇÀ» ¿øÇϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

°³¹ß ¿ëµµ(ÀÓ»ó Áø´Ü, ÀǾàǰ °³¹ß, ±âŸ ¿ëµµ), ÃÖÁ¾ ¿ëµµ(º´¿ø, Áø´Ü ¼¾ÅÍ, Á¦¾àȸ»ç, ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷, ¼öŹ ¿¬±¸±â°ü, Çмú¿¬±¸±â°ü), ¸ð´Þ¸®Æ¼(º¥Ä¡Å¾Çü, ÇÃ·Î¾î ½ºÅĵù), Á¦Ç° À¯Çü(¹ÝÀÚµ¿ »ýÈ­ÇÐ ºÐ¼®±â, ÀüÀÚµ¿ »ýÈ­ÇÐ ºÐ¼®±â)

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹

AI ÅëÇÕ

¿ì¸®´Â °ËÁõµÈ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI Åø·Î ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM³ª ¾÷°è °íÀ¯ SLM¸¦ Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹ü¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾ç ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÔ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Blood Cell Analyzer Market to Reach US$2.7 Billion by 2030

The global market for Blood Cell Analyzer estimated at US$2.1 Billion in the year 2024, is expected to reach US$2.7 Billion by 2030, growing at a CAGR of 4.8% over the analysis period 2024-2030. Semi-automated Biochemistry Analyzers, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$687.6 Million by the end of the analysis period. Growth in the Fully Automated Biochemistry Analyzers segment is estimated at 5.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$561.3 Million While China is Forecast to Grow at 4.4% CAGR

The Blood Cell Analyzer market in the U.S. is estimated at US$561.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$425.6 Million by the year 2030 trailing a CAGR of 4.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.7% and 3.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.9% CAGR.

Global Blood Cell Analyzer Market - Key Trends & Drivers Summarized

Why Is There a Surge in Demand for Blood Cell Analyzers Globally?

The demand for blood cell analyzers has surged due to the growing need for precise and rapid diagnostic tools in healthcare. Blood cell analyzers are critical in diagnosing a variety of medical conditions, including infections, anemia, cancer, and cardiovascular diseases. With the increasing prevalence of these diseases, particularly in aging populations, healthcare providers are turning to advanced blood cell analysis technologies to enhance patient outcomes. These devices enable healthcare professionals to conduct detailed assessments of blood samples, measuring cell count, morphology, and abnormalities, all while delivering fast and accurate results. As healthcare shifts toward preventive care and early diagnosis, the role of blood cell analyzers becomes even more critical.

How Are Technological Innovations Transforming Blood Cell Analyzers?

Technological advancements are at the forefront of the blood cell analyzer market's growth, leading to more efficient, accurate, and multifunctional devices. The integration of artificial intelligence (AI) and machine learning into these analyzers has enabled faster, automated diagnostics with minimal human intervention, reducing the chances of errors and increasing laboratory efficiency. Furthermore, advancements in flow cytometry and hematology have allowed for a more detailed analysis of blood samples, including identifying rare blood disorders. Portable and point-of-care blood analyzers have also gained popularity, allowing for diagnostics in decentralized settings such as clinics, rural hospitals, and even at-home care scenarios.

What Impact Do Emerging Markets Have on the Blood Cell Analyzer Industry?

Emerging markets are playing an increasingly significant role in the blood cell analyzer industry, contributing to its growth. Developing nations, particularly in Asia-Pacific and Latin America, are witnessing a rise in healthcare spending, expanding access to diagnostic services. As healthcare infrastructure improves in these regions, there is a growing need for modern diagnostic tools, including blood cell analyzers. Government initiatives aimed at expanding healthcare access and screening programs for diseases like cancer and diabetes are driving the adoption of advanced diagnostic equipment. Moreover, increasing awareness of preventive healthcare and early diagnosis is boosting the demand for blood analyzers in these regions.

The Growth in the Blood Cell Analyzer Market Is Driven by Several Factors

The growth in the blood cell analyzer market is driven by several factors, including technological advancements, the rising prevalence of chronic and infectious diseases, and increased healthcare expenditure in emerging markets. An aging global population and the subsequent rise in age-related conditions are major contributors to the growing demand for these diagnostic tools. Additionally, the increasing trend toward automation in laboratories, driven by the need for faster and more accurate results, is further propelling the adoption of blood cell analyzers. Point-of-care testing, home-based diagnostics, and the shift toward preventive healthcare are also playing a pivotal role in expanding the market, as consumers and healthcare providers alike seek more accessible and efficient diagnostic solutions.

SCOPE OF STUDY:

The report analyzes the Blood Cell Analyzer market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Clinical Diagnostics, Drug development, Other Applications); End-Use (Hospitals, Diagnostic Centers, Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations, Academic Research Institutes); Modality (Bench-top, Floor-standing); Product Type (Semi-automated Biochemistry Analyzers, Fully Automated Biochemistry Analyzers)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 43 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â